Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2015

01-05-2015 | Original Article

High prevalence of complementary and alternative medicine use in patients with genetically proven mitochondrial disorders

Authors: Sebastian Franik, Hidde H. Huidekoper, Gepke Visser, Maaike de Vries, Lonneke de Boer, Marion Hermans-Peters, Richard Rodenburg, Chris Verhaak, Arine M. Vlieger, Jan A. M. Smeitink, Mirian C. H. Janssen, Saskia B. Wortmann

Published in: Journal of Inherited Metabolic Disease | Issue 3/2015

Login to get access

Abstract

Despite major advances in understanding the pathophysiology of mitochondrial diseases, clinical management of these conditions remains largely supportive, and no effective treatment is available. We therefore assumed that the burden of disease combined with the lack of adequate treatment leaves open a big market for complementary and alternative medicine use. The objective of this study was to evaluate the use and perceived effectiveness of complementary and alternative medicine in children and adults with genetically proven mitochondrial disease. The reported use was surprisingly high, with 88 % of children and 91 % of adults having used some kind of complementary and alternative medicine in the last 2 years. Also, the mean cost of these treatments was impressive, being €489/year for children and €359/year for adult patients. Over-the-counter remedies (e.g., food supplements, homeopathy) and self-help techniques (e.g., Reiki, yoga) were the most frequently used complementary and alternative therapies in our cohort: 54 % of children and 60 % of adults reported the various complementary and alternative medicine therapies to be effective. Given the fact that currently no effective treatment exists, further research toward the different therapies is needed, as our study clearly demonstrates that such therapies are highly sought after by affected patients.
Appendix
Available only for authorised users
Literature
go back to reference Balwani M, Fuerstman L, Desnick R, Buckley B, McGovern M (2009) Use of complementary and alternative medicine by patients with lysosomal storage diseases. Genet Med Off J Am Coll Med Genet 11(10):722–727 Balwani M, Fuerstman L, Desnick R, Buckley B, McGovern M (2009) Use of complementary and alternative medicine by patients with lysosomal storage diseases. Genet Med Off J Am Coll Med Genet 11(10):722–727
go back to reference Bishop F, Prescott P, Chan Y, Saville J, von Elm E, Lewith G (2010) Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics 125(4):768–776CrossRefPubMed Bishop F, Prescott P, Chan Y, Saville J, von Elm E, Lewith G (2010) Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics 125(4):768–776CrossRefPubMed
go back to reference Emmanuele V, López LC, López L et al (2012) Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. Arch Neurol 69(8):978–983PubMedCentralPubMed Emmanuele V, López LC, López L et al (2012) Heterogeneity of coenzyme Q10 deficiency: patient study and literature review. Arch Neurol 69(8):978–983PubMedCentralPubMed
go back to reference Koene S, Jansen M, Verhaak CM, De Vrueh RL, De Groot IJ, Smeitink JA (2013) Towards the harmonization of outcome measures in children with mitochondrial disorders. Dev Med Child Neurol 55(8):698–706PubMed Koene S, Jansen M, Verhaak CM, De Vrueh RL, De Groot IJ, Smeitink JA (2013) Towards the harmonization of outcome measures in children with mitochondrial disorders. Dev Med Child Neurol 55(8):698–706PubMed
go back to reference Koopman WJ, Willems PH, Smeitink JA (2012) Monogenic mitochondrial disorders. N Engl J Med 366(12):1132–1141CrossRefPubMed Koopman WJ, Willems PH, Smeitink JA (2012) Monogenic mitochondrial disorders. N Engl J Med 366(12):1132–1141CrossRefPubMed
go back to reference Madsen H, Andersen S, Nielsen RG, Dolmer BS, Høst A, Damkier A (2003) Use of complementary/alternative medicine among paediatric patients. Eur J Pediatr 162(5):334–341PubMed Madsen H, Andersen S, Nielsen RG, Dolmer BS, Høst A, Damkier A (2003) Use of complementary/alternative medicine among paediatric patients. Eur J Pediatr 162(5):334–341PubMed
go back to reference Nabukera SK, Romitti PA, Campbell KA et al (2012) Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy. J Child Neurol 27(6):734–740CrossRefPubMed Nabukera SK, Romitti PA, Campbell KA et al (2012) Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy. J Child Neurol 27(6):734–740CrossRefPubMed
go back to reference Niggemann B, Grüber C (2003) Side-effects of complementary and alternative medicine. Allergy 58(8):707–716CrossRefPubMed Niggemann B, Grüber C (2003) Side-effects of complementary and alternative medicine. Allergy 58(8):707–716CrossRefPubMed
go back to reference Parikh S, Goldstein A, Koenig MK et al (2013) Practice patterns of mitochondrial disease physicians in North America. Part 2: treatment, care and management. Mitochondrion 13(6):681–687CrossRefPubMed Parikh S, Goldstein A, Koenig MK et al (2013) Practice patterns of mitochondrial disease physicians in North America. Part 2: treatment, care and management. Mitochondrion 13(6):681–687CrossRefPubMed
go back to reference Pfeffer G, Horvath R, Klopstock T et al (2013) New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol 9(8):474–481CrossRefPubMed Pfeffer G, Horvath R, Klopstock T et al (2013) New treatments for mitochondrial disease-no time to drop our standards. Nat Rev Neurol 9(8):474–481CrossRefPubMed
go back to reference Quandt S, Verhoef M, Arcury T et al (2009) Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). J Altern Complement Med (New York, NY) 15(4):331–339CrossRef Quandt S, Verhoef M, Arcury T et al (2009) Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). J Altern Complement Med (New York, NY) 15(4):331–339CrossRef
go back to reference Singendonk M, Kaspers G-J, Naafs-Wilstra M, Meeteren A, Loeffen J, Vlieger A (2013) High prevalence of complementary and alternative medicine use in the Dutch pediatric oncology population: a multicenter survey. Eur J Pediatr 172(1):31–37CrossRefPubMed Singendonk M, Kaspers G-J, Naafs-Wilstra M, Meeteren A, Loeffen J, Vlieger A (2013) High prevalence of complementary and alternative medicine use in the Dutch pediatric oncology population: a multicenter survey. Eur J Pediatr 172(1):31–37CrossRefPubMed
go back to reference Tindle HA, Davis RB, Phillips RS, Eisenberg DM (2005) Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med 11(1):42–49PubMed Tindle HA, Davis RB, Phillips RS, Eisenberg DM (2005) Trends in use of complementary and alternative medicine by US adults: 1997–2002. Altern Ther Health Med 11(1):42–49PubMed
go back to reference Vlieger A, van de Putte E, Hoeksma H (2006) The use of complementary and alternative medicine in children at a general paediatric clinic and parental reasons for use. Ned Tijdschr Geneeskd 150(11):625–630PubMed Vlieger A, van de Putte E, Hoeksma H (2006) The use of complementary and alternative medicine in children at a general paediatric clinic and parental reasons for use. Ned Tijdschr Geneeskd 150(11):625–630PubMed
Metadata
Title
High prevalence of complementary and alternative medicine use in patients with genetically proven mitochondrial disorders
Authors
Sebastian Franik
Hidde H. Huidekoper
Gepke Visser
Maaike de Vries
Lonneke de Boer
Marion Hermans-Peters
Richard Rodenburg
Chris Verhaak
Arine M. Vlieger
Jan A. M. Smeitink
Mirian C. H. Janssen
Saskia B. Wortmann
Publication date
01-05-2015
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2015
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-014-9773-9

Other articles of this Issue 3/2015

Journal of Inherited Metabolic Disease 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine